Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1982 Sep-Dec;55(5-6):529–531.

A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.

F Rosenfelt, J Palmer, I Weinstein, B Rosenbloom
PMCID: PMC2596537  PMID: 6190321

Abstract

Bleomycin is an effective drug used in the therapy of many malignant diseases. Such toxicities as fever, chills, and pulmonary fibrosis are well known to occur following administration of this drug. A rare fatal hyperpyrexial response has also been noted with this agent. We describe a case of fatal hyperthermia after an injection of bleomycin. Unlike earlier reported cases, our patient developed her reaction following prior uneventful therapy with bleomycin rather than as a response to initial treatment. Factors that may be related to the hyperpyrexial response to bleomycin are discussed and the relevant literature reviewed.

Full text

PDF
529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M., Reich S. D. Bleomycin. Ann Intern Med. 1979 Jun;90(6):945–948. doi: 10.7326/0003-4819-90-6-945. [DOI] [PubMed] [Google Scholar]
  2. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  3. Dinarello C. A., Ward S. B., Wolff S. M. Pyrogenic properties of bleomycin (NSC-125066). Cancer Chemother Rep. 1973 Nov-Dec;57(4):393–398. [PubMed] [Google Scholar]
  4. Durkin W. J., Pugh R. P., Solomon J., Rosen P., Pajak T. F., Bateman J. R. Treatment of advanced lymphomas with bleomycin (NSC-125066). Oncology. 1976;33(3):140–145. doi: 10.1159/000225128. [DOI] [PubMed] [Google Scholar]
  5. Levy R. L., Chiarillo S. Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration. Oncology. 1980;37(5):316–317. doi: 10.1159/000225462. [DOI] [PubMed] [Google Scholar]
  6. Ma D. D., Isbister J. P. Cytotoxic-induced fulminant hyperpyrexia. Cancer. 1980 May 1;45(9):2249–2251. doi: 10.1002/1097-0142(19800501)45:9<2249::aid-cncr2820450905>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  7. Mosher M. B., DeConti R. C., Bertino J. R. Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers. Cancer. 1972 Jul;30(1):56–60. doi: 10.1002/1097-0142(197207)30:1<56::aid-cncr2820300109>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  8. Oken M. M., Loch J. Corticosteroid and antihistamine modification of bleomycin-induced fever. Proc Soc Exp Biol Med. 1979 Sep;161(4):594–596. doi: 10.3181/00379727-161-40603. [DOI] [PubMed] [Google Scholar]
  9. Rudders R. A. Treatment of advanced malignant lymphomas with bleomycin. Blood. 1972 Sep;40(3):317–332. [PubMed] [Google Scholar]
  10. Yagoda A., Mukherji B., Young C., Etcubanas E., Lamonte C., Smith J. R., Tan C. T., Krakoff I. H. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. Ann Intern Med. 1972 Dec;77(6):861–870. doi: 10.7326/0003-4819-77-6-861. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES